Pharmafile Logo
Pharmafocus logo
Advanced Search

generics

Showing 15 posts of 209 posts found.

reckitt benckiser image

Merck, Reckitt Benckiser fined by French watchdog

December 20, 2013
Manufacturing and Production, Sales and Marketing FCA, Merck, Reckitt Benckiser, generics, subutex

Merck & Co and Reckitt Benckiser have collectively been fined millions of euros by French authorities over their role in …

News
Levin image

Teva boss quits over Board struggles

October 31, 2013
Medical Communications, Sales and Marketing Copaxone, Levin, Teva, generics

Teva’s president and chief executive Dr Jeremy Levin has unexpectedly quit as the firm struggles with staff cuts and management …

News

Viagra patent expiry opens up market

June 24, 2013
Manufacturing and Production, Research and Development, Sales and Marketing ED, Pfizer, generics, viagra

Pfizer lost its UK patent rights to its erectile dysfunction drug Viagra over the weekend, leading to an influx of …

News
Ranbaxy image

Ranbaxy unit fined $500m for selling adulterated drugs

May 14, 2013
Manufacturing and Production FDA, GMP, Ranbaxy, fine, generics

Ranbaxy’s US subsidiary has agreed to pay fines and penalties totalling $500 million after pleading guilty to charges of manufacturing …

News

Novartis’ 2012 results flat

January 24, 2013
Sales and Marketing Bexsero, Jakavi, Novartis, generics, results

Generic competition has put a dent in Novartis’ financial results for 2012, with net sales down 3% year on year …

News

India plans ban on branded generics

October 18, 2012
Manufacturing and Production, Sales and Marketing India, generics

India is moving ahead with plans to ban the sale of branded generics in the country, adding to marketplace concerns …

News

Pharma is recovering, says Moody’s

September 25, 2012
Business Services, Manufacturing and Production, Research and Development, Sales and Marketing Moody's, Plavix, austerity, generics, pharma

Credit ratings agency Moody’s believes that the travails of the past few years, when various big-selling drugs went off-patent, are …

News

Pfizer and Hisun sign China generics deal

September 13, 2012
Manufacturing and Production, Sales and Marketing China, Pfizer, branded generics, emerging markets, generics

Pfizer has unveiled a new joint venture with with China’s Zhejiang Hisun Pharmaceuticals. It is one of the first joint …

News
Pfizer image

Pfizer and Mylan sign Japanese generics deal

August 23, 2012
Sales and Marketing Mylan, Pfizer, generics

Pfizer and Mylan have struck a deal to sell generic drugs together in Japan, the world’s second biggest pharma market. …

News
Novartis image

Novartis’ Indian patent case delayed

August 23, 2012
Sales and Marketing Glivec, MSF, Novartis, generics

Novartis’ court case against the Indian government has been put on hold until next month. The case was suppose to …

News
GSK HQ

GSK sheds Australian generics unit for £172m

August 15, 2012
Sales and Marketing Aspen Global, GSK, generics

GlaxoSmithKline has divested the majority of its Australian generics unit to Aspen Global, a firm it partly owns. The South …

News

Former Teva president joins Sun Pharma

June 7, 2012
Business Services, Manufacturing and Production, Research and Development, Sales and Marketing Sun Pharma, Teva, generics, manufacturing

Sun Pharma has appointed Israel Makov as its new chairman of the board. Makov is the former president and chief …

Appointment
Novartis image

Novartis to acquire Fougera for $1.5 billion

May 3, 2012
Sales and Marketing Fougera, Novartis, dermatology, generics, gilenya

Novartis will acquire the dermatology generics firm Fougera for $1.53 billion in cash.  Novartis’ generic unit Sandoz is conducting the …

News

Watson buys Actavis to create generics giant

April 27, 2012
Sales and Marketing Actavis, Watson, generics

Watson Pharmaceuticals is to buy rival Actavis Group in a move that will create the third largest generics manufacturer in …

News

Novartis Q1 earnings slide down

April 26, 2012
Sales and Marketing Novartis, Q1, Sandoz, generics, gilenya

Generic competition and problems at a US plant were among the reasons why Novartis’ sales and profit dipped in the …

News
The Gateway to Local Adoption Series

Latest content

BMS’ Opdivo/Yervoy combination accepted by Scottish Medicines Consortium for colorectal cancer

February 5, 2026

AstronauTx appoints Adam Rosenberg as Chair of the Board

February 5, 2026

Astellas Pharma’s Vyloy accepted by Scottish Medicines Consortium for gastric cancer

February 4, 2026

Angelini Pharma appoints Sergio Marullo di Condojanni as CEO

February 4, 2026

QV Bioelectronics secures £4.5m in funding for brain cancer therapy development

February 3, 2026